rupiya.io
⠋Loading sector...
0%
❯ Building sector comparison...
Hospital chains scaling bed capacity while diagnostics benefit from preventive health awareness and insurance penetration.
| Company | M.Cap | Price | P/E | P/B | ROE | ROCE | D/E | Div Yield | 1Y Return |
|---|---|---|---|---|---|---|---|---|---|
| Lenskart Solutions Ltd | ₹1,11,955 Cr | ₹646.6 | 174.8 | 12.9 | 6.8% | 5.8% | 0.4 | 0.0% | +49.6% |
| Sai Life Sciences Ltd | ₹33,231 Cr | — | 92.4 | 13.3 | 15.1% | 16.8% | 0.1 | 0.0% | +72.76% |
| Dr. Lal PathLabs Ltd | — | — | — | — | 21.8% | 24.9% | 0.1 | — | +38.11% |
| Inventurus Knowledge Solutions Ltd | — | — | — | — | 31.5% | 28.4% | 0.3 | — | +2.52% |
| Sagility Ltd | — | — | — | — | 10.3% | 11.7% | 0.1 | — | -12.73% |
| Poly Medicure Ltd | — | — | — | — | 10.9% | 13.0% | 0.1 | — | -2.54% |
| Vijaya Diagnostic Centre Ltd | — | — | — | — | 19.7% | 16.9% | 0.4 | — | +47.55% |
| Dr. Agarwals Health Care Ltd | ₹15,064 Cr | ₹475.15 | 102.2 | 7.4 | 8.6% | 7.2% | 0.5 | 0.0% | +0.18% |
| Syngene International Ltd | ₹14,465 Cr | ₹359.9 | 65.6 | 3.0 | 6.6% | 7.5% | 0.1 | 0.4% | -43.07% |
| Indegene Ltd | ₹14,334 Cr | ₹595.2 | 35.9 | 4.6 | 13.9% | 14.9% | 0.1 | 0.4% | +16.86% |
| Metropolis Healthcare Ltd | ₹11,010 Cr | ₹530.7 | 54.7 | 7.3 | 13.4% | 14.4% | 0.2 | 0.4% | +15.13% |
| Thyrocare Technologies Ltd | ₹7,582 Cr | ₹476.35 | 43.2 | 13.0 | 28.8% | 33.4% | 0.1 | 2.0% | +2.71% |
| Krsnaa Diagnostics Ltd | — | — | — | — | 10.8% | 8.4% | 0.5 | — | -25.41% |
| Fischer Medical Ventures Ltd | — | — | — | — | 8.6% | 11.4% | 0.3 | — | -35.6% |
| Tarsons Products Ltd | ₹1,628 Cr | ₹306 | 146.4 | 2.6 | 2.2% | 2.4% | 0.6 | 0.0% | +41.14% |
| Suraksha Diagnostic Ltd | ₹1,594 Cr | ₹306 | 44.5 | 6.5 | 13.6% | 11.6% | 0.5 | 0.2% | +15.08% |
| Laxmi Dental Ltd | — | — | — | — | 12.8% | 10.9% | 0.1 | — | -25.27% |
| Fabtech Technologies Ltd | ₹553 Cr | — | 10.1 | 1.1 | 12.8% | 11.7% | 0.2 | 0.5% | -33.9% |
| Universus Photo Imagings Ltd | ₹471 Cr | ₹429.9 | — | 0.6 | -9.5% | -9.6% | 0.0 | 0.0% | +91.75% |
| Nureca Ltd | ₹317 Cr | ₹316.9 | 64.4 | 1.6 | 1.1% | 2.7% | 0.0 | 0.0% | +19.98% |
| Choksi Laboratories Ltd | — | — | — | — | 8.0% | 6.5% | 1.3 | — | +79.98% |
| Choksi Asia Ltd | — | — | — | — | 13.5% | 17.4% | 0.1 | — | +90.56% |
| Maestros Electronics & Telecommunications Systems Ltd | ₹94 Cr | — | 12.6 | 2.2 | 18.8% | 18.0% | 0.0 | 0.0% | -41.3% |
| Shree Pacetronix Ltd | ₹63 Cr | — | 19.2 | 3.4 | 19.7% | 22.8% | 0.2 | 0.0% | +105.64% |
| Centenial Surgical Suture Ltd | ₹33 Cr | — | — | 1.2 | -7.4% | -4.3% | 1.1 | 0.0% | -8.63% |
| GKB Ophthalmics Ltd | ₹31 Cr | — | 9.8 | 0.6 | 5.7% | 4.9% | 0.2 | 0.0% | -16.95% |
| Deep Health AI India Ltd | — | — | — | — | 3.1% | 3.1% | 0.0 | — | -64.61% |
India's healthcare sector is valued at $372 billion and growing at 15-20% annually. Hospital bed density at 1.3 per 1,000 people is among the lowest globally, creating a massive expansion opportunity. Listed hospital chains (Apollo, Max, Fortis) are adding beds aggressively while improving ARPOB (Average Revenue Per Occupied Bed).
Medical tourism brings $9 billion annually with India offering procedures at 1/10th the cost of the US. Health insurance penetration is rising rapidly from a low base, making healthcare more accessible. Key metrics: ARPOB, occupancy rates, bed additions, and payor mix (insurance vs out-of-pocket).
The sector trades at premium valuations (40-60x PE) due to scarcity and structural tailwinds.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.